Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
to simulate damage, and use and develop new physiological, morphological, cell and molecular biological analysis techniques. You will conduct training and supervision of students at all levels, including
-
relevant standard and advanced characterization techniques for protein systems as well as obtain insights into relevant coarse-grained modeling and simulation. Your main work tasks will be Conduct your
-
-edge computational tools for modeling and analysis. The postdoctoral researcher will work within multidisciplinary teams in close industrial collaboration, contributing to both experimental and
-
neurobiology, including damage mechanisms and neurodegeneration. You will use the technologies used by the unit to simulate damage, and use and develop new physiological, morphological, cell and molecular
-
neurobiology, including damage mechanisms and neurodegeneration. You will use the technologies used by the unit to simulate damage, and use and develop new physiological, morphological, cell and molecular
-
the unit to simulate damage, and use and develop new physiological, morphological, cell and molecular biological analysis techniques. You will conduct training and supervision of students at all levels
-
interested in translational neurobiology, including damage mechanisms and neurodegeneration. You will use the technologies used by the unit to simulate damage, and use and develop new physiological
-
modeling, device physics, nanotechnology, biotechnology, and system design. Our activities span the range from basic research to commercialization, the latter carried out in close collaboration with
-
use the data to train deep learning models of cancer. This allows us to identify systems-level mechanisms that can be used to uncover new biomarkers, drug targets, and paths to drug resistance. We
-
use the data to train deep learning models of cancer. This allows us to identify systems-level mechanisms that can be used to uncover new biomarkers, drug targets, and paths to drug resistance. We